{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-214188","form_type":"8-K","ticker":"ALGS","cik":"0001799448","company_name":"Aligos Therapeutics, Inc.","filed_at":"2024-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.557942+00:00","generated_at":"2026-05-31T06:17:15.582311+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Aligos Therapeutics regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq letter on Sept 3, 2024 confirming compliance with Minimum Bid Price Requirement.","Previous deficiency letter was dated Sept 5, 2023; stock had closed below $1.00 for 30 consecutive days.","Compliance achieved under Nasdaq Listing Rules 5450(a)(1) and 5550(a)(2); matter is closed.","No additional financial or operational details provided in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-214188","json":"https://secwatch.observer/filing/0001193125-24-214188.json","markdown":"https://secwatch.observer/filing/0001193125-24-214188.md","text":"https://secwatch.observer/filing/0001193125-24-214188.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799448/000119312524214188/0001193125-24-214188-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799448/000119312524214188/d857897d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:17:15.582311+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}